VEGFA and ablepharon macrostomia syndrome: The development of AMS is a multifactorial incidence characterized by elevated cerebral blood flow, an imbalance in cerebral autoregulation and an increase in hypoxic mediators like nitrite oxide, prostaglandins, and VEGF (Hackett and Roach, 2001; Wilson et al., 2009).